Page 37 - Pharma

Honeywell completes acquisition of Sigma-Aldrich's research chemicals business

The move broadens Honeywell's research chemicals portfolio and expands global reach

Glenmark settles Para IV litigation with Forest Labs for generic Savella

The company has signed a settlement agreement with Forest Laboratories for the generic of Savella, which is indicated for the management of fibromyalgia

Leading pharma companies' R&D returns continue to slide

Study produced by Deloitte in collaboration with GlobalData says R&D returns for 12 leading pharmaceutical companies have more than halved since 2010

Arkema arm Bostik opens adhesives plant in Mexico

The new plant, which will produce hot melt pressure sensitive adhesives (HMPSA), will primarily serve the needs of customers in the disposable hygiene sector

Bal Pharma to gain from anti-dumping duty on Chinese gliclazide

Ministry of Finance had imposed anti-dumping duty on gliclazide imported from China as the domestic industry has suffered material injury

TCS joins hand with US university to advance life sciences research

The company, along with Vanderbilt University Medical Center, will drive specific research in areas such as genomics, systems biology, bio-informatics, advanced healthcare analytics, etc

Biocon UAE venture partners with Novartis to launch diabetes drugs

NeoBiocon - a venture between Biocon and Neopharma - will partner with Novartis to market two products - vildagliptin and vildagliptin-metformin combination drug

Pharma outsourcing M&As set for a record in 2015: Report

As per GlobalData analyst, value of pharma outsourcing mergers and acquisitions deals has more than doubled from $ 5.5 billion in 2014 to $ 12 billion by October 2015

Wockhardt receives US FDA's drug discovery status for new antibiotic

The company has received QIDP status, which provides fast track clinical development and review of the drug application by US FDA, for its new anti-infectives

Nostrum Labs buys Sun Pharma's US manufacturing unit

The divestment is aimed at consolidating Sun Pharma's manufacturing operations in the US

Sun Pharma ink research pact with Israel's Weizmann & Spain's IDIS

The company has entered into a tripartite research agreement with these two institutes to develop breakthrough products for the treatment of neurological diseases

The cardio factor: An insight into heart disease

While there are more than 300 indications under the category of heart disease and related disorders, the top 10 indications account for nearly 57% of the total registered clinical trials

Work on AIIMS cancer institute starts at Jhajjar

Modelled on the National Cancer Institute of USA, the institute will lead for all activities related to cancer in the country

Natco receives DCGI nod for hepatitis C drug daclatasvir

Daclatasvir is used in combination with sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 3 infection

Natco settles infringement suit for generic Tamiflu

The Hyderabad-based company and its partner Alvogen have settled the infringement suit with Gilead, Roche & others for generic Tamiflu in New Jersey District Court

Alembic Swiss unit Rhizen Pharma inks out-licensing deal with Novartis

License agreement with Novartis has been signed for Rhizen's inhaled dual PI3K-delta gamma inhibitor

Lubrizol to invest $ 15 mn in lifesciences business

With this, Lubrizol aims to expand its global manufacturing facilities, positioning lifesciences business to better serve the growing market for medical device contract manufacturing

Daiichi Sankyo to shut down German R&D unit

The move is aimed at strengthening its global research and development capabilities by increasing efficiency and streamlining processes

Upto 70% dietary supplements sold in Indian market are fake: Report

Indian dietary supplements market, currently estimated at about $2 billion, is expected to almost double to $ 4 billion by 2020, says Assocham-RNCOS study

Dr Reddy's inks pact with LSSSDC and VIPER for skill development

The MoU will also collaborate to create pharma, biotech and clinical research occupation standards, as well as establish a competency matrix for job roles in the pharmaceutical sector